AUPH - Aurinia Pharmaceuticals Inc
IEX Last Trade
6.81
-0.090 -1.322%
Share volume: 1,127,663
Last Updated: Fri 30 Aug 2024 09:59:59 PM CEST
Research and Development in Biotechnology (except Nanobiotechnology):
0.21%
PREVIOUS CLOSE
CHG
CHG%
$6.90
-0.09
-1.30%
Summary score
13%
Profitability
0%
Dept financing
4%
Liquidity
50%
Performance
20%
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
Long-term ratios 30-Jun-2016 - 30-Jun-2020
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
-14.6%
Return on assets
-9.24%
Return on sales
-28276.56%
Return on invested capital
-3596.86%
Total debt ratio
19.67%
Debt ratio change over timeo
-1.24%
Current Ratio
22.04%
Quick Ratio
0%
Cash Position Ratio
19.22%
Short-term ratios 30-Jun-2019 - 30-Jun-2020
The data are presented for the financials results of the quarters of the last year.
Return on equity
-15.49%
Return on assets
-9.88%
Return on sales
0%
Return on invested capital
-13758.9%
Total debt ratio
17.41%
Debt ratio change over timeo
-1.02%
Current Ratio
18.85%
Quick Ratio
0%
Cash Position Ratio
17.49%
Last quarter ratios 30-Jun-2020
The data are presented for the financials results of the last quarter.
Return on equity
-12.35%
Return on assets
-9.17%
Return on sales
0%
Return on invested capital
-25453.45%
Total debt ratio
19.05%
Debt ratio change over time
-1.03%
Current Ratio
16.22%
Quick Ratio
0%
Cash Position Ratio
13.56%
Performance ratios (change over 4 years) 30-Jun-2016 - 30-Jun-2020
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
-81.48%
Return on assets
-89.42%
Return on sales
65699.65%
Return on invested capital
194.45%
Total debt ratio
-124.46%
Debt ratio change over time
-1.24%
Current Ratio
-20.69%
Quick Ratio
0%
Cash Position Ratio
-14.83%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | AUPH | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | -14.6% | -3.05% | 11.55% | 6.27% |
| Return on assets | -9.24% | 3.6% | 3.57% | 5.27% |
| Return on sales | -28276.56% | 32.14% | 42.16% | 33.08% |
| Return on invested capital | -3596.86% | 5.09% | 7.99% | 13.19% |
| Profitability | 0% | 46% | 82% | 83% |
| Total debt ratio | 19.67% | 101.18% | 74.11% | 29.58% |
| Debt ratio change over time | -1.24% | 6.09% | 6.03% | 1.53% |
| Dept financing | 5% | 50% | 43% | 14% |
| Current Ratio | 18.85% | 2.08% | 2.02% | 3.51% |
| Quick Ratio | 0% | 1.96% | 1.71% | 2.86% |
| Cash Position Ratio | 17.49% | 1.48% | 0.76% | 1.49% |
| Liquididy | 50% | 13% | 30% | 29% |
| Short-term ratios | AUPH | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | -15.49% | -25.62% | 17.94% | 7.14% |
| Return on assets | -9.88% | 3.26% | 3.67% | 4.71% |
| Return on sales | 0% | 31.22% | 37.5% | 33.58% |
| Return on invested capital | -13758.9% | 8.14% | 7.17% | 18.16% |
| Profitability | 0% | 49% | 79% | 82% |
| Total debt ratio | 17.41% | 105.33% | 83.42% | 27.49% |
| Debt ratio change over time | -1.02% | -23.44% | 9.66% | 0.6% |
| Dept financing | 4% | 25% | 45% | 8% |
| Current Ratio | 18.85% | 2.08% | 2.02% | 3.51% |
| Quick Ratio | 0% | 1.96% | 1.71% | 2.86% |
| Cash Position Ratio | 17.49% | 1.48% | 0.76% | 1.49% |
| Liquididy | 50% | 22% | 19% | 32% |